FindTrial
Sign In

Serum profiles of paracetamol and glutathione after high doses of paracetamol for six days

Serum profiles of paracetamol and glutathione after high doses of paracetamol for six days

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-005690-22-IS
Enrollment
Unknown
Registered
2006-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Trade Name: Panodil Pharmaceutical Form: Tablet INN or Proposed INN: paracetamol

Sponsors

University of Iceland
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy, age 18-60 years. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: History of liver or kidney diseases, history of alcohol abuse, chronic drug use, allergy for paracetamol.

Design outcomes

Primary

MeasureTime frame
Main Objective: To describe the pharmacokinetics after large doses for 6 days.;Secondary Objective: To study the possible changes in the blood concentration of glutathione.;Primary end point(s): Blood concentrations of paracetamol and glutathione. Pharmacokinetic parameters for paracetamol.—

Countries

Iceland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026